Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rhythm Pharmaceuticals (RYTM) Change in Intangibles: 2023-2024

Historic Change in Intangibles for Rhythm Pharmaceuticals (RYTM) over the last 1 years, with Sep 2024 value amounting to $500,000.

  • Rhythm Pharmaceuticals' Change in Intangibles rose 83.82% to $500,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $41.6 million, marking a year-over-year change of. This contributed to the annual value of $40.5 million for FY2024, which is 614.66% up from last year.
  • As of Q3 2024, Rhythm Pharmaceuticals' Change in Intangibles stood at $500,000, which was down 98.75% from $40.0 million recorded in Q1 2024.
  • In the past 5 years, Rhythm Pharmaceuticals' Change in Intangibles registered a high of $40.0 million during Q1 2024, and its lowest value of $272,000 during Q3 2023.
  • Over the past 2 years, Rhythm Pharmaceuticals' median Change in Intangibles value was $875,000 (recorded in 2023), while the average stood at $9.2 million.
  • Data for Rhythm Pharmaceuticals' Change in Intangibles shows a peak YoY skyrocketed of 784.96% (in 2024) over the last 5 years.
  • Quarterly analysis of 2 years shows Rhythm Pharmaceuticals' Change in Intangibles stood at $272,000 in 2023, then soared by 83.82% to $500,000 in 2024.
  • Its Change in Intangibles was $500,000 in Q3 2024, compared to $40.0 million in Q1 2024 and $272,000 in Q3 2023.